SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-016125
Filing Date
2022-06-08
Accepted
2022-06-07 20:41:14
Documents
75
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 844747
2 ex31-1.htm EX-31.1 20203
3 ex31-2.htm EX-31.2 20333
4 ex32-1.htm EX-32.1 6826
5 ex32-2.htm EX-32.2 6999
  Complete submission text file 0001493152-22-016125.txt   4982071

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adxs-20220430.xsd EX-101.SCH 42040
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adxs-20220430_cal.xml EX-101.CAL 64069
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adxs-20220430_def.xml EX-101.DEF 155515
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adxs-20220430_lab.xml EX-101.LAB 332138
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adxs-20220430_pre.xml EX-101.PRE 269229
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 827320
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 221002395
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences